Anger is a multi-dimensional concept ranging from feeling irritable to violent aggression. A growing body of literature suggests the relevance of sleep in regard to anger. The current study aims to review previous studies on the association between anger and diverse aspects of sleep including sleep disruption, chronotype, sleep disorders and sleep deprivation. An association between sleep and anger has been observed starting in the early stage of life, with sleep of infants or toddlers affecting emotional and behavioral aspects of anger. However, the association between anger and sleep is not clear in adolescents and might be due to the effects of psychosocial factors on both sleep and anger during adolescence. Subjective but not objective sleep disturbances of adults have been also associated with anger. Evening types showed more anger, which might be mediated by psychological characteristics or social jet lag of evening people. Increased anger has also been found in those with insomnia, sleep apnea, or experimental sleep-deprivation. Previous studies have reported that diverse sleep disturbances are related to anger. Future study assessing the various sleep or circadian indices and considering the multidimensional aspects of anger are needed.

With an incidence of 1 per 2,500-3,000 individuals, neurofibromatosis type 1 (NF1) is the most common autosomal dominant disorder in humans. NF1 is caused by germline mutations of the NF1 gene, but to date genotype-phenotype analyses have indicated no clear relationship between specific gene mutations and the clinical features of this disease, even among family members with the same mutation. The present study describes a case of two siblings with NF1 with the same genetic mutation but different clinical manifestations. The first patient was a female with iris Lisch nodules, an adrenal incidentaloma, Graves' disease, and skin manifestations, while the second patient, the first patient's younger brother, exhibited only skin neurofibromas and freckling. Further study is needed to reveal the molecular processes underlying gene expression and phenotypes. A better understanding of the genetics associated with NF1 will allow clinicians to detect complications earlier and provide better genetic counseling to NF1 families.
Female ; Gene Expression ; Genes, Neurofibromatosis 1* ; Genetic Counseling ; Genetics ; Germ-Line Mutation ; Graves Disease ; Humans ; Incidence ; Iris ; Neurofibroma ; Neurofibromatoses* ; Neurofibromatosis 1* ; Phenotype ; Siblings ; Skin ; Skin Manifestations